Around one in eight American adults currently uses a GLP-1. In Australia it is closer to one in fifty, and the gap matters if anyone is building a range on the strength of American data. Roughly half a million Australians use these medicines, most of them paying privately. Overseas, Image Skincare has made GLP-1 Skin a permanent concern category and BondiBoost sells a GLP-1 set into Ulta. None of that naming survives contact with Australian law, and the opening sits in the pr